Anti-factor Xa activity assays of direct-acting oral anticoagulants during clinical care: An observational study.

Sukumar, Smrithi; Cabero, Melissa; Tiu, Sharon; Fang, Margaret C; Kogan, Scott C; Schwartz, Janice B

Sukumar, Smrithi; Cabero, Melissa; Tiu, Sharon; Fang, Margaret C; Kogan, Scott C; Schwartz, Janice B.

Afiliación

Sukumar S; School of Medicine University of California San Francisco CA USA.
Cabero M; Clinical Laboratory of UCSF Medical Center San Francisco CA USA.
Tiu S; Clinical Laboratory of UCSF Medical Center San Francisco CA USA.
Fang MC; Department of Medicine University of California San Francisco CA USA.
Kogan SC; Laboratory Medicine University of California San Francisco CA USA.
Schwartz JB; Department of Medicine University of California San Francisco CA USA.

Res Pract Thromb Haemost ; 5(4): e12528, 2021 May.

Article en En | MEDLINE | ID: mdl-34013157

Palabras clave

antifactor Xa activity assay; apixaban; direct oral anticoagulant; retrospective electronic medical record; rivaroxaban

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies Idioma: En Revista: Res Pract Thromb Haemost Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google